Back to Search
Start Over
Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression.
- Source :
-
Internal and emergency medicine [Intern Emerg Med] 2013 Sep; Vol. 8 (6), pp. 485-91. Date of Electronic Publication: 2011 May 17. - Publication Year :
- 2013
-
Abstract
- Low bone mineral density, which increases the risk of stress fragility fractures, is a frequent, often persistent finding in patients with major depressive disorder (MDD). The clinical association between major depressive disorder and osteopenia is still unclear, although several factors are associated with a loss of bone mass. The aim of our study, therefore, was to evaluate bone mineral density and bone metabolism in patients with MDD. Bone mineral density was evaluated in fifty postmenopausal women with MDD, and in 50 matched postmenopausal control women by dual-energy X-ray absorptiometry of the lumbar spine and femur, and by ultrasonography of the calcaneus and phalanges. Serum levels of 25-hydroxivitamin D, parathyroid hormone, Osteoprotegerin/Receptor Activator for Nuclear Factor κB Ligand ratio, bone turnover markers, serum and urinary cortisol were examined. Bone mineral density of the lumbar spine (BMD: 0.72 ± 0.06 vs. 0.82 ± 0.09 g/cm(2), p < 0.001), femoral neck (BMD: 0.58 ± 0.04 vs. 0.71 ± 0.07 g/cm(2), p < 0.001) and total femur (BMD 0.66 ± 0.09 vs. 0.54 ± 0.06 g/cm(2), p < 0.001); and ultrasound parameters at calcaneus (SI: 81.30 ± 6.10 vs. 93.80 ± 7.10, p < 0.001) and phalanges (AD-SOS: 1915.00 ± 37.70 vs. 2020.88 ± 39.46, p < 0.001; BTT : 1.30 ± 0.8 vs. 1.45 ± 0.9, p < 0.001) are significantly lower in patients with MDD compared with controls. Moreover bone turnover markers, parathyroid hormone levels and Receptor Activator for Nuclear Factor κB Ligand are significantly higher in MDD patients compared with controls, while serum levels of 25-hydroxivitamin D and osteoprotegerin are significantly lower. There are no differences in urinary excretion and serum cortisol between groups. Postmenopausal women with depressive disorder have an elevated risk for osteoporosis. Our data suggest that a high level of parathyroid hormone may play a role in the pathogenetic process underlying osteopenia in these patients.
- Subjects :
- Bone Diseases, Metabolic epidemiology
Bone Remodeling physiology
Calcaneus diagnostic imaging
Cholecalciferol blood
Comorbidity
Depressive Disorder, Major blood
Depressive Disorder, Major epidemiology
Disease Progression
Female
Finger Phalanges diagnostic imaging
Humans
Middle Aged
Parathyroid Hormone blood
Postmenopause
Risk Factors
Ultrasonography
Bone Density
Depressive Disorder, Major physiopathology
Subjects
Details
- Language :
- English
- ISSN :
- 1970-9366
- Volume :
- 8
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Internal and emergency medicine
- Publication Type :
- Academic Journal
- Accession number :
- 21584846
- Full Text :
- https://doi.org/10.1007/s11739-011-0628-1